Healthcare Compliance

CDRH Grants Variance to University of Texas at Austin

FDA CDRH issued a variance approval to The University of Texas at Austin on April 22, 2026, granting an exception to standard medical device regulatory requirements under the referenced variance proceeding. The variance allows UT Austin to conduct specified activities that would otherwise require separate FDA authorization under 21 CFR Part 812. The approval is documented under docket FDA-2026-V-3707 and is effective upon issuance.

FDA CDER Letter to USPTO April 15 2026

FDA Center for Drug Evaluation and Research (CDER) transmitted correspondence to the United States Patent and Trademark Office (USPTO) dated April 15, 2026. The document listing on regulations.gov indicates two PDF attachments are available for download; however, the substantive content of the letters is not displayed in the public-facing page. This appears to be inter-agency correspondence related to patent examination matters.

FDA CTP Complaint Filed Under Moa-747a-495v Tracking Number

The FDA Center for Tobacco Products (CTP) filed a formal complaint document with tracking reference moa-747a-495v. The document attachment is available for download but the regulatory content is not accessible in the source listing. The complaint was submitted through the official FDA regulations.gov docket system under reference FDA-2026-H-3998-0001.

FDA CDRH Approves Variance for Trio Charlotte

FDA's Center for Devices and Radiological Health (CDRH) has approved a variance for Trio Charlotte, granting regulatory relief from specific medical device requirements under FDA jurisdiction. The variance approval letter was issued under docket FDA-2026-V-2880-0003. This individual variance applies specifically to Trio Charlotte and does not establish broader precedent for other medical device manufacturers seeking similar relief.

FDA Approves Redhouse Productions Variance, Apr 22

FDA CDRH issued a variance renewal approval letter to Redhouse Productions on April 22, 2024, extending an existing regulatory variance. The variance renewal allows Redhouse Productions to continue operating under modified regulatory terms for the device or activity covered by the original variance. Variance renewals maintain the holder's existing regulatory flexibility while confirming continued compliance with applicable requirements.

FDA CDER Letter to USPTO, Apr 22 (FDA-2020-E-2185-0006)

FDA's Center for Drug Evaluation and Research (CDER) issued a letter to the U.S. Patent and Trademark Office on April 22, filed as document FDA-2020-E-2185-0006 on regulations.gov. The document is listed as an attachment available for download but the full letter content is not displayed in the source page. This appears to be a patent-related submission from FDA's drug evaluation center to the USPTO.

FDA DMB Acknowledgment Letter to Visual Oasis LLC

FDA CDRH's Device Management Branch issued an acknowledgment letter to Visual Oasis LLC in connection with a voluntary submission (FDA-2026-V-2432). The letter confirms receipt of the submission but does not constitute approval, clearance, or authorization of any kind. No regulatory action, product approval, or compliance obligation is conveyed by this correspondence.

Letter from FDA CDER to USPTO, Apr 15

FDA CDER issued correspondence to the USPTO containing two PDF attachments. The primary document body states no documents are available to view or download directly. The attachments appear to be inter-agency communications related to a patent matter filed under docket FDA-2024-E-3588. This type of correspondence typically addresses patent term extension applications, patent listings, or other drug patent-related matters referred by the USPTO.

HRSA Extends Rural Communities Opioid Response Program Funding

HRSA has issued a one-time 1-year funding extension for the Rural Communities Opioid Response Program—Behavioral Health Care Technical Assistance (RCORP-TA) cooperative agreement. The current recipient, JBS International, Inc (award U6BRH32364), will receive $10,000,000 to continue providing technical assistance to rural organizations developing multi-sector consortia for behavioral health and opioid use disorder services. The extended project period runs from September 1, 2026 through August 31, 2027.

Respiratory Muscle Training Trial, ANZCTR, Spain, Recruiting

The Universidad de Sevilla registered a randomised controlled trial on ANZCTR investigating the impact of different instructional strategies on respiratory muscle activation during inspiratory muscle training in healthy adults. The interventional study uses the POWERbreathe Kinetic K5 device across four experimental conditions and has ethics approval from the Comité de Ética de la Investigación de la Universidad de Sevilla (CEIUS). The trial is currently recruiting in Sevilla, Spain, with a target sample size of 24 participants.

Prostate Cancer Brachytherapy Trial, NSW, Recruiting

This is a clinical trial registration for a study evaluating ultra-hypofractionated external beam radiation therapy combined with risk-adapted brachytherapy boost for localised prostate cancer. The trial, named HYBRID (ACTRN12626000509369p), is sponsored by South Eastern Sydney Local Health District through St George Hospital and is currently recruiting in NSW, Australia. The study aims to enrol 176 male patients with clinically localised prostate cancer, with anticipated first participant enrolment on 1 July 2026. Ethics approval is currently submitted and pending.

3D Printed Metamaterial Insoles for Diabetes-Related Foot Ulceration

The Australian New Zealand Clinical Trials Registry (ANZCTR) has registered ACTRN12626000508370, a prospective within-subjects crossover study evaluating 3D printed functionally graded metamaterial insoles for reducing plantar pressures in adults at risk of diabetes-related foot ulceration. The trial received ethics approval on 16/04/2026 and was registered on 23/04/2026. Participants will attend two appointments where plantar pressures will be measured barefoot and in trial footwear, with personalised insoles designed using an automated algorithm based on individual pressure profiles.

A-PATH Trial, Domestic Abuse Support, Women 60+, Recruiting

The A-PATH clinical trial (ISRCTN16469112) is a prospectively registered, multi-site, randomized controlled feasibility study evaluating an adapted psychological support intervention for women aged 60 and older affected by domestic abuse in England and Wales. The study aims to recruit 131 participants across urban and rural sites between April 2026 and March 2029, testing the acceptability and effectiveness of the adapted A-PATH programme compared to standard domestic abuse advocacy support. Ethics approval was granted on 12 March 2026 by the London Stanmore Research Ethics Committee (ref: 26/PR/0105) and the trial is currently open to recruitment.

End of Life Care Study, Rural Coastal Devon Cornwall Somerset

A new observational clinical trial has been registered on ISRCTN studying end-of-life care provision in rural and coastal communities across Devon, Cornwall and Somerset. The 28-month participatory realist evaluation is sponsored by University of Plymouth and funded by the National Institute for Health and Care Research (£167,160). The study began recruiting on 20 February 2026 with a target enrollment of 320 participants including patients, family carers and health/social care professionals, and runs until January 2028.

SAFE Study Tests Support for Autistic Families

The SAFE study (ISRCTN89355835) has been registered on the ISRCTN clinical trials registry. The randomised controlled trial will evaluate the SAFE (Systemic Autism-related Family Enabling) support package plus usual care versus usual care alone for families of autistic children aged 3-16 years with level 1 or 2 autism. The trial is sponsored by Devon Partnership NHS Trust, funded by the NIHR Health Technology Assessment Programme, and will recruit families at multiple UK sites from August 2026 through March 2029.

TROPICCANA HPV-Detect Blood Test Cervical Cancer Monitoring Trial

The TROPICCANA observational cohort trial is recruiting approximately 3000 UK patients annually diagnosed with HPV-caused cervix cancer to validate the HPV-detect blood test (circulating HPV-DNA via ddPCR) as a predictor of residual disease following chemoradiotherapy. The Royal Marsden NHS Foundation Trust-sponsored study runs from January 2026 to July 2030, with ethics approval granted 26/01/2026 by South Central - Oxford A REC (ref: 26/SC/0016). Participants donate blood samples before and during treatment without additional clinical visits or altered treatment plans.

ISRCTN51391184: DNA Methylation Analysis on Self-Samples for Cervical Cancer Detection

Self-screen B.V. has registered an observational multi-center equivalence study (ISRCTN51391184) evaluating the clinical performance of the PreCursor-M Gold DNA methylation assay on self-collected vaginal specimens for cervical cancer detection. The study, approved by the Ministry of Health of Republic of Uzbekistan Ethics Committee on 09/02/2026, will recruit approximately 250 women in Tashkent, Uzbekistan to obtain 140 high-risk HPV-positive participants (70 with CIN3+ and 70 without disease or ≤CIN1). Both self-collected Floqswab samples and clinician-taken cervical smears will be tested at Amsterdam University Medical Center for equivalence comparison against the PreCursor-M+ reference method.

Respiratory-Swallow Training Trial for Head and Neck Cancer

The University of Liverpool has registered a prospective randomised controlled trial (ISRCTN12055450) evaluating respiratory-swallow training as an intervention for dysphagia in patients who have completed head and neck cancer treatment. The trial, funded by the National Institute for Health and Care Research (NIHR303061) and approved through IRAS 335217, will recruit participants from NHS sites who finished curative-intent cancer treatment at least 3 months ago. Participants will be randomised to receive up to 6 weeks of weekly swallow training with biofeedback equipment or to a control group receiving no training, with follow-up at one week and three months post-training.

MA Pharmacy Board Issues Guidance on Medication Administration

The Board of Registration in Pharmacy issued guidance on pharmacist administration of medications, effective March 11, 2026. The document provides the board's regulatory framework governing how pharmacists may administer medications within their scope of practice in Massachusetts. Pharmacists and pharmacy operators should obtain and review the full guidance to ensure their medication administration practices comply with current board standards.

Weather-Health Alert System User Guide

UKHSA published a user guide for the Weather-Health Alert system, operated jointly with the Met Office to issue Heat-Health Alerts (June 1 to September 30) and Cold-Health Alerts (November 1 to March 30). Users must register on the system specifying their government region to receive alerts, which are triggered by joint dynamic risk assessments when weather episodes are forecast to impact health. Alerts communicate risk to NHS England, the government, and the public health system, with advice sent to health and social care professionals working with at-risk groups.

FY 2025-26 Q2 MQA Quarterly Performance Report Released

The Florida Department of Health's Division of Medical Quality Assurance (MQA) has released the FY 2025-26 Quarterly Performance Report for Quarter Two, covering MQA's key trends in licensing, enforcement, and information along with insights into MQA's financials. The report is required under sections 456.005 and 456.025(9), Florida Statutes, and provides quarterly snapshots of key performance statistics for MQA staff, decision-makers, board and council members, consumers, and other stakeholders. The announcement also references MQA initiatives including HB 975 Cleared to Care campaign, MQA's Virtual Agent ELI, and unlicensed activity outreach activities.

MiPLUS Help: Apply, Renew, Track License Online

The Michigan Professional Licensing User System (MiPLUS) is the Department of Licensing and Regulatory Affairs, Bureau of Professional Licensing's online licensing and regulatory database application for health and occupational professionals in Michigan. The system enables applicants to apply online, track application status, and receive electronic notifications, while licensees can renew licenses and modify existing licensing information. This help page provides instructions for registration, application, modification, and renewal processes using MiPLUS.

Michigan Board of Nursing Meeting Agendas and Minutes 2025–2026

The Michigan Board of Nursing maintains a public index of board meeting agendas and disciplinary subcommittee meeting minutes, organized by date in reverse chronological order. Documents span from January 2025 through April 2026 and include both full board and disciplinary subcommittee materials, with several agendas marked as amended. PDFs are hosted by the Michigan Department of Licensing and Regulatory Affairs (LARA) Bureau of Professional Licensing.

Michigan Board of Nursing Authority Origins and Membership

The Michigan Board of Nursing publishes its authority origins and current membership composition. The Board was originally created under the Nurse Practice Act of 1909, with authority transferred to the Nursing Practice Act of 1967 and finally to the Public Health Code of 1978. The Public Health Code establishes the Board's powers including nurse licensure qualifications, education program standards, competency assurance, and disciplinary authority. The Board consists of 24 members: 9 registered nurses, 1 nurse midwife, 1 nurse anesthetist, 1 nurse practitioner, 3 licensed practical nurses, and 8 public members. The page lists current named members with their represented seats and term expiration dates through June 2029.

NY Nursing Board Advisory Notices Index

The NY Nursing Board hub page lists nine advisory notices including a workforce survey requirement for registered professional nurses, New York's BSN in 10 law, mandated reporter training updates, and COVID-19 resources. The page serves as a central index for NY-licensed nurses and employers to access multiple regulatory updates from a single location. No single compliance obligation or deadline is established by this index page itself.

New Online Application Tracker for MA Nursing Licensure Is Live

The Massachusetts Board of Registration in Nursing launched a newly designed online application tracker on April 8, 2026, available to new applicants seeking nursing licensure and advanced practice authorization. The tracker provides real-time visibility into application review stages, estimated processing times, and status updates, along with contact resources for applicant inquiries. This is an administrative process improvement; no new compliance obligations, fees, or regulatory requirements are imposed on applicants.

NIH-Funded AI Model Predicts Cancer Survival from Single-Cell Tumor Data

Researchers at Oregon Health & Science University (OHSU), supported by NIH's National Cancer Institute, developed scSurvival, a machine learning model that analyzes single-cell tumor data to predict patient survival outcomes. The model was validated on clinical data from more than 150 cancer patients with melanoma and liver cancer, demonstrating improved accuracy over traditional methods by identifying specific immune and tumor cell populations associated with treatment response and survival risk.

NIH-Funded CRISPR Breakthrough Enables Precision Delivery for Cancer, ALS

NIH-funded researchers at UT Austin discovered an enhanced CRISPR gene-editing system (Al3Cas12f) small enough for targeted delivery in the human body using adeno-associated virus vectors. The engineered variant (Al3Cas12f RKK) improved editing efficiency from less than 10% to more than 80%, potentially enabling treatments for cancer, ALS, and other diseases.

Dr. Jonathan M. Green Selected CEO of NIH Clinical Center

NIH has selected Dr. Jonathan M. Green as chief executive officer of the NIH Clinical Center, the world's largest hospital devoted to clinical research. Dr. Green will begin his role on May 17, 2026, overseeing the Clinical Center's nearly $700 million annual operating budget, its 200-bed, 870,000-square-foot research center on NIH's Bethesda campus, and an ongoing expansion adding over 570,000 square feet of space expected to be completed in 2029. The Clinical Center recorded over 3,000 inpatient admissions and nearly 72,000 outpatient visits last year, with every patient enrolled in a research protocol.

PIERCING DEVICE FOR AN ADMINISTRATION DEVICE EP3863698A1 mylife Diabetes Care

The European Patent Office published patent application EP3863698A1 titled 'Piercing Device for an Administration Device' on April 15, 2026. The patent was filed by mylife Diabetes Care AG with inventors STREIT, Ursina, HOSTETTLER, Patrick, HOFER, Christophe, and MARGOT, Roland. The invention relates to A61M medical devices and is designated for all EU member states plus other EPC contracting states.

EP3928814A1 Wearable Drug Delivery Device, Apr 15, 2026

The European Patent Office published application EP3928814A1 on April 15, 2026, covering a wearable drug delivery device filed by mylife Diabetes Care AG. The application carries IPC classifications A61M 5/142 and A61M 5/158 and designates 31 contracting states including Germany, France, the United Kingdom, Italy, Spain, and other EU member states. Six inventors are credited: Baumert, Jan, Hanimann, Michael, Margot, Roland, Streit, Ursina, Bosshard, Simon, and Steiner, Fabian.

Methods for Promoting Hair Growth - EP3801734A1

The European Patent Office granted patent EP3801734A1 to Follica, Inc. on April 15, 2026, titled 'Methods for Promoting Hair Growth.' The patent application covers hair growth promotion methods under IPC classifications A61M 37/00, A61P 17/14, and A61Q 7/02. The designated states include all EU member states plus associated countries (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Drug Depot Delivery System for Image-Guided Targeting, Murphy

The EPO published patent application EP3752239A1 for a drug depot delivery system designed for image-guided targeting to a target site. The application names Murphy, Kieran P. as both applicant and inventor under IPC classifications A61M (medical preparations delivery devices) and A61B (diagnostic instruments). The patent designates all EU member states plus associated countries as covered territories.

Adjustable Curved Sheath Tube And Stent Delivery Device

The European Patent Office has published patent EP3903742A1 for an adjustable curved sheath tube and stent delivery device, filed by Hangzhou Endonom Medtech Co., Ltd (inventors: WANG, Yongsheng; LI, Jianmin). The patent, classified under A61F 2/95 and A61M 25/092, covers a medical device designed to facilitate curved sheath tube adjustment during stent delivery procedures. The publication grants EPO intellectual property rights across 31 designated contracting and extension states.

Ball Lock Assembly Retention Pin EP3880279A1

The European Patent Office granted European patent application EP3880279A1 to Pulse NeedleFree Systems, LLC for a ball lock assembly with retention pin used in medical injection devices. The patent, filed by inventor Mikhail Zolotukhin, covers A61M 5/48 and A61M 5/315 classifications and is designated valid in 31 European member states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.

Lymphatic System Drug Delivery Patent EP3801464A1

The European Patent Office published patent application EP3801464A1 titled 'Drug Delivery Methods Targeting the Lymphatic System' on April 15, 2026. The patent applicant is Vivasor, Inc., with inventor Russell Frederick ROS, and covers IPC classifications A61K 9/00, A61M 37/00, A61P 35/00, and A61P 35/04. The designated states include all EPC contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Ventec Life Systems EP3976229A1 Medical Gas Concentrator, Apr 15

EPO published European Patent Application EP3976229A1 on April 15, 2026, filed by Ventec Life Systems, Inc. The patent covers a system and method for concentrating medical gas. Named inventors are Haneh Y. Yehya, Alex P. Valentine, and Michael J. Budinger. The application designates all EU member states plus Switzerland, Norway, Turkey, and other European countries.

Guide Extension Catheter EP3908197A1, Teleflex, Apr 15

The European Patent Office granted patent EP3908197A1 to Teleflex Life Sciences LLC on April 15, 2026, for a guide extension catheter. The patent lists Joshua Brenizer, Dean Peterson, Thomas Kouchoukos, and Mark Wendle as inventors, with IPC classifications covering catheter and valve devices. The patent confers exclusive rights to Teleflex for the stated term from filing.

European Patent, Blood Flow Regulation, LivaNova, 15th Apr

The European Patent Office published application EP4132605A1 for LivaNova Deutschland GmbH, covering a method and system for regulating blood flow in extracorporeal circulation. The application was published April 15, 2026, with inventors Penka and Schubert listed, and classified under A61M 1/36 and related A61M 60/ categories. The patent designates all contracting states including DE, FR, GB, NL, IT, ES, and 25 other European jurisdictions.

Fresenius Medical Care Accuracy Checking Method

The European Patent Office published patent application EP3914314A1 by Fresenius Medical Care Deutschland GmbH on April 15, 2026, covering a method and device for checking the accuracy of conveying means in medical treatment devices. The application lists inventor Joachim Noack with IPC classifications A61M 1/16 and A61M 1/34. The designated states cover major European markets including Germany, France, the United Kingdom, Italy, and Spain.

Ejection Device for Syringes EP3721923A1

The European Patent Office published patent application EP3721923A1 titled 'Ejection Device for Syringes', filed by applicant and inventor Heiden, Klemens. The application covers medical device technology classified under IPC subclass A61M, specifically relating to syringe ejection and dosage mechanisms. The publication designates 35 contracting states across Europe.

Veronica Wong Joins, Export Restrictions Move to APHIS

Veronica Wong joins the Office of Food Safety as Chief of Staff, bringing experience from USDA's Research, Education and Economics mission area and Office of Congressional Relations. FSIS relocated animal health export restrictions for U.S. animal products for human consumption to the Animal and Plant Health Inspection Service website as of April 1, 2026, affecting products subject to restrictions based on Foreign Animal Diseases including Highly Pathogenic Avian Influenza, Newcastle Disease, African Swine Fever, and Foot and Mouth Disease. On April 6, a new landing page at ask.fsis.usda.gov will consolidate over 1,200 consumer Q&As and 800 inspection policy Q&As from askFSIS, the Small Plant Help Desk, and the Meat & Poultry Hotline.

FSIS Posts Q4 FY2025 Residue Report, Updates WGS Sequencing Method

FSIS posted its National Residue Program Quarterly Report for July to September 2025 covering residue sampling data for domestic surveillance, inspector-generated, and import programs for Q4 of fiscal year 2025. The agency also announced an update to its whole genome sequencing laboratory method to incorporate the Illumina MiSeq i100 platform, with integration beginning in May 2026 across FSIS laboratories. Multiple public comment periods are open through May 26, 2026 for information collection renewals covering sanitation SOPs, line speed rates, nutrition labeling, and other topics.

FSIS Leadership Changes, Import Refusal Data, Consumer Complaints Update

Dr. Melanie Abley has been named Acting Assistant Administrator for the Office of Public Health Science (OPHS) at FSIS, and Mr. Terry Dutko has been named OPHS Acting Deputy Assistant Administrator, both following prior roles within FSIS. The agency has released the FY 2025 Consumer Complaints annual summary and updated the Import Presented Refused and Import Refusal Reason datasets covering FY 2014 through the most recent FY. Multiple comment periods are open until May 26, including renewals of approved information collections for nutrition labeling, PHIS, new technology waivers, and voluntary destruction procedures. The Small Plant Forum engaged approximately 30 small and very small processors with FSIS subject matter experts on key regulatory topics.

EMS for Children Advisory Committee to Meet Thursday, Apr. 23, 2026

The South Carolina Department of Public Health announces the EMS for Children Advisory Committee will meet Thursday, April 23, 2026, at 10 a.m. at the State of South Carolina Health Campus, Conference Room B228, 400 Otarre Parkway, Cayce. The agenda and virtual viewing link are available on the meeting event page.

Former Pharmacy President Adam Brosius Sentenced to 24 Months for $33M Healthcare Fraud and Kickback Scheme

Adam Brosius, 61, of Delray Beach, Florida, was sentenced to 24 months in prison on April 1, 2026 for his role in a $33 million health care fraud and kickback scheme involving compounded medications. Brosius and co-conspirators used Main Avenue Pharmacy, a mail-order pharmacy with a Clifton, New Jersey storefront, to distribute medically unnecessary scar creams, pain creams, migraine medication, and vitamins from 2014 through 2016. Brosius served as the pharmacy's director of business development before becoming its president.

Illegal Alien Charged with Healthcare Fraud, Aggravated Identity Theft

Amaurys Arias Arias, 44, a Dominican national unlawfully residing in Brockton, Massachusetts, was arrested and charged with one count of making false statements relating to health care matters and one count of aggravated identity theft. The defendant allegedly used the stolen identity of a U.S. citizen to obtain MassHealth benefits, falsely representing himself as a U.S. citizen in applications and sworn affidavits. Arias is alleged to have obtained tens of thousands of dollars in government healthcare benefits through the stolen identity, and also used the stolen identity in connection with prior arrests leading to convictions in the victim's name.

Indian Health Service Directs $700 Million in Infrastructure Funds to Tribal Water Projects

The Indian Health Service announced FY 2026 allocations of $700 million from the Infrastructure Investment and Jobs Act to support drinking water and sanitation projects across Indian Country. The funding represents the fifth year of IIJA appropriations, which provides $3.5 billion to IHS between FY 2022 and FY 2026 for critical Tribal water infrastructure including drinking water sources, sewage systems, and solid waste disposal facilities. The allocations follow Tribal leaders' recommendations to prioritize projects that have completed planning and are ready to move directly into design and construction.

Georgia DPH Warns of Wildfire Smoke Health Risks

The Georgia Department of Public Health (DPH) has issued health precautions as shifting winds push smoke from South Georgia wildfires into metro Atlanta and other parts of the state. The advisory identifies vulnerable populations including people with respiratory conditions, young children, pregnant women, and elderly individuals who face heightened health risks from particle exposure. DPH recommends limiting outdoor activities, monitoring air quality reports, keeping windows closed, running air conditioners with clean filters, and following medical provider guidance for existing conditions.